Oscotec Inc.

KOSDAQ 039200.KQ

Oscotec Inc. Capital Expenditure for the year ending December 31, 2023: USD -446.38 K

Oscotec Inc. Capital Expenditure is USD -446.38 K for the year ending December 31, 2023, a 54.77% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).
  • Oscotec Inc. Capital Expenditure for the year ending December 31, 2022 was USD -986.83 K, a 88.60% change year over year.
  • Oscotec Inc. Capital Expenditure for the year ending December 31, 2021 was USD -8.66 M, a -80.60% change year over year.
  • Oscotec Inc. Capital Expenditure for the year ending December 31, 2020 was USD -4.79 M, a -19.16% change year over year.
  • Oscotec Inc. Capital Expenditure for the year ending December 31, 2019 was USD -4.02 M, a -99.91% change year over year.
Key data
Date Capital Expenditure Free Cash Flow Depreciation And Amortization Deferred Income Tax
Market news
Loading...
SV Wall Street
KOSDAQ: 039200.KQ

Oscotec Inc.

CEO Sung-Hee Son
IPO Date Jan. 17, 2007
Location South Korea
Headquarters A Building, Korea Bio Park
Employees 50
Sector Healthcare
Industries
Description

Oscotec Inc. operates as a clinical stage drug discovery and development company. It develops SYK inhibitor that is in Phase IIa clinical trial to treat rheumatoid arthritis and immune thrombocytopenia; FLT3 inhibitor, which is in Phase I clinical trial for the treatment of acute myeloid leukemia; and EGFR double mutation inhibitor to treat non-small cell lung cancer, as well as Anti-Tau antibody, which is in preclinical Phase for the treatment of Alzheimer's disease. The company also offers dental health products, such as bone graft comprising InduCera, BioCera-F, and SynCeraII; and membrane consisting of LysoGide and CollaGuide. In addition, it provides functional ingredients comprises OPB for osteoporosis; AIF for arthritis; SGA that enhance bone growth; and PRF-K for perio diseases. The company was formerly known as Oscotec Co., Ltd and changed its name to Oscotec Inc. in June 1999. Oscotec Inc. was founded in 1988 and is based in Seongnam, South Korea.

Similar companies

000100.KS

Yuhan Corporation

USD 83.97

-5.00%

006280.KS

Green Cross Corporation

USD 88.80

-5.65%

095700.KQ

Genexine, Inc.

USD 3.04

-3.81%

StockViz Staff

February 5, 2025

Any question? Send us an email